Ionis Pharmaceuticals (NASDAQ:IONS) executives used the company’s fourth-quarter and full-year 2025 earnings call to highlight what CEO Brett Monia called a “defining year,” pointing to the successful ...
15h
Kip Kniskern
Author Kip Kniskern. Owner and Managing Editor of OnMSFT.com LLC since November 2018. Long time Microsoft watcher since the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results